Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside

Research output: Book/ReportBookpeer-review

Abstract

This book provides a state-of-the-art overview of acute lymphoblastic leukemia (ALL). The first section of the book presents the translational science behind ALL, reviewing molecular pathways and targets in B- and T-cell ALL, as well as techniques and application of minimal residual disease testing. The second section spotlights ALL management strategies for patients across the spectrum, from infants to the elderly. The final section outlines current and new advances in ALL treatment, including new monoclonal antibodies and allogenic and autologous HSCT. Written by experts in the field, Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside is a valuable resource that will guide patient management, stimulate investigative efforts, and increase understanding of the biologic underpinnings of the disease.

Original languageEnglish
PublisherSpringer International Publishing
Number of pages437
ISBN (Electronic)9783030851477
ISBN (Print)9783030851460
DOIs
StatePublished - 1 Jan 2022
Externally publishedYes

Keywords

  • B-cell ALL
  • CAR-T
  • HSCT
  • Minimal residual disease testing
  • Monoclonal antibodies
  • T-cell ALL

Fingerprint

Dive into the research topics of 'Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside'. Together they form a unique fingerprint.

Cite this